close

Global IT Outage Update

Every day we care for and treat hundreds of patients from Greater Manchester and beyond who come through our doors.

 

Today's global IT outage affected many organisations including ours but to put it into context, this outage affected less than a third of our patients.

 

Our staff worked tirelessly to deliver as many chemotherapy and immunotherapy treatments as possible and continue to finalise plans for those we were unable to see today due to issues affecting our supplier.

 

Thank you for being understanding and bearing with us. Unless our teams contact you, please attend for your appointment as planned.

 

We continue to work with our supplier to resolve this issue and prioritise our most clinically urgent patients. We apologise for any delays that have occurred as a result of this.

 

Any further updates will be published on our website and social media channels (Facebook and X/Twitter)

Skip to Content

The Christie is a member of King’s International Consortium

6 of the most innovative and internationally recognised NHS healthcare providers working together

King’s International Consortium, the UK’s first with the support of the NHS Export Collaborative, was established on 24 January 2023 at an event in London, presided over by Lord Prior, former Chair of the NHS. 

The Christie was one of 5 founding consortium members, along with King’s College Hospital NHS Foundation Trust, Guy’s and St Thomas’ NHS Foundation Trust, Cambridge University Hospitals NHS Foundation Trust and Moorfields Eye Hospital NHS Foundation Trust. South London and Maudsley NHS Foundation Trust became the sixth member to join in April 2023.

The Christie is a member of King’s International Consortium

The establishment of the consortium is part of the 2019 NHS long-term plan. It aims to generate additional income and investment for the benefit of NHS patients, with backing from the NHS Export Collaborative, Healthcare UK, NHS England and the Department of Health and Social Care.  

Members of the King’s International Consortium have a wealth of combined experience in delivering excellent and high-quality care to patients, both across the UK and internationally. The members also have a proven record of accomplishment in delivering international projects and offering expertise across all clinical specialities. 

Membership of the consortium will enable The Christie NHS Foundation Trust to build on its previous experience advising on large scale international projects including:

Christine Outram MBE, Chair for The Christie; Charles Alexander, Joint Chair for Guy’s and St Thomas’ and King’s; Dr Mike More, Chair for Cambridge University Hospitals; and Ros Given-Wilson, Interim Chair for Moorfields gave the consortium their joint support.  

“We are delighted to have established King’s International Consortium, which brings together five of the most innovative and internationally recognised healthcare providers from the UK’s National Health Service (NHS).

“The aim of King’s International Consortium is to export British healthcare collaboratively, by working in partnership with external investors to deliver large-scale international healthcare projects, to market our world-class capabilities and to bring in additional income and investment for the benefit of NHS patients.

“This innovation, the first of its kind in the UK, will strengthen our position as being leaders in the field of exporting NHS standards of care and quality.  

“We are grateful to the NHS Export Collaborative and Healthcare UK, as well as NHS England and The Department of Health and Social Care. We are committed to ensuring the Kings International Consortium is a success for its partners and the NHS.”

King’s International Consortium will be managed via King’s Commercial Services, with oncology advice and education provided to clients by The Christie’s clinical, technical and operational experts, facilitated by The Christie International team.

Last updated: December 2023